Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Se otorga el mejor beneficio
PMID 24636400 2.The Safety of Human Chorionic Gonadotropin Monotherapy Among Men With Previous Exogenous Testosterone Use
p53-mediated activation of miRNA34 candidate tumor-suppressor genes
Methods We used the Korea National Health and Nutrition Examination Survey data (2019 to 2021, n =2,665) for the evaluation of prevalence, comorbidities, control rate of glycemia and comorbidities in DKD, and the Korean Health Insurance Service-customized database (2008 to 2019, n =3,950,857) for the evaluation of trends in the incidence and prevalence rate of diabetes-related ESKD, renin-angiotensin system (RAS) blockers and sodium glucose cotransporter 2 (SGLT2) inhibitors use for DKD, and the risk of atherosclerotic cardiovascular disease (ASCVD) and mortality according to DKD stages
US$ 22.21
US$ 24.52
US$ 25.66
